SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $2,348,000 | +20.0% | 98,432 | +3.6% | 0.00% | 0.0% |
Q1 2021 | $1,956,000 | -55.9% | 95,009 | -47.6% | 0.00% | 0.0% |
Q4 2020 | $4,438,000 | +38.9% | 181,144 | +57.1% | 0.00% | -40.0% |
Q3 2020 | $3,194,000 | +527.5% | 115,333 | +7.8% | 0.01% | +400.0% |
Q2 2020 | $509,000 | +73.1% | 107,030 | +20.7% | 0.00% | 0.0% |
Q1 2020 | $294,000 | -3.9% | 88,654 | 0.0% | 0.00% | – |
Q4 2019 | $306,000 | -12.1% | 88,654 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $348,000 | +22.1% | 88,654 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $285,000 | -77.9% | 88,654 | -52.7% | 0.00% | -50.0% |
Q1 2019 | $1,288,000 | +96.6% | 187,458 | +29.4% | 0.00% | +100.0% |
Q4 2018 | $655,000 | -36.2% | 144,874 | +7.2% | 0.00% | -50.0% |
Q3 2018 | $1,026,000 | -17.5% | 135,166 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,244,000 | +157.0% | 135,166 | +104.9% | 0.00% | +100.0% |
Q1 2018 | $484,000 | -27.7% | 65,961 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $669,000 | -38.5% | 65,961 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $1,088,000 | – | 65,961 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |